Tekmira Announces Filing of Shelf Prospectus and Registration Statement

[GlobeNewswire] – VANCOUVER, British Columbia — Tekmira Pharmaceuticals Corporation , a developer of RNA interference (RNAi) therapeutics, today announced that it has filed a preliminary short form base shelf prospectus … more

View todays social media effects on TKMR

View the latest stocks trending across Twitter. Click to view dashboard

See who Tekmira is hiring next, click here to view